References
- Gold J A, Shupack J L, Nemec M A. Ocular side effects of the retinoids. Int J Dermatol 1989; 28: 218–225
- Hanson N, Leachman S. Safety issues in isotretinoin therapy. Semin Cutan Med Surg 2001; 20: 166–183
- Gross E G, Helfgott M A. Retinoids and the eye. Dermatol Clin 1992; 10: 521–531
- Caffery B E, Josephson J E. Ocular side effects of isotretinoin therapy. J Am Optom Assoc 1988; 59: 221–224
- Lambert R W, Smith R E. Pathogenesis of blepharoconjunctivitis complicating 13‐cis‐retinoic acid(isotretinoin) therapy in a laboratory model. Invest Ophthalmol Vis Sci 1988; 29: 1559–1564
- Kremer I, Gaton D D, David M, Gaton E, Shapiro A. Toxic effects of systemic retinoids on meibomian glands. Ophthalmic Res 1994; 26: 124–128
- Egger S F, Huber‐Spitzy V, Bohler K, Scholda C. Isotretinoin administration in treatment of acne vulgaris. A prospective study of the kind and extent of ocular complications. Ophthalmologe 1995; 92: 17–20
- Bozkurt B, Irkec M T, Atakan N, Orhan M, Geyik P O. Lacrimal function and ocular complications in patients treated with systemic isotretinoin. Eur J Ophthalmol 2002; 12: 173–176
- Mathers W D, Shields W J, Sachdev M S, Petroll W M, Jester J V. Meibomian gland morphology and tear osmolarity: changes with Accutane therapy. Cornea 1991; 10: 286–290
- Fraunfelder F T, La Braico J M, Meyer S M. Adverse ocular reactions possibly associated with isotretinoin. Am J Ophthalmol 1985; 100: 534–537
- Heuberger A, Buchi E R. Irreversible cataract as a possible side effect of isotretinoin. Klin Monatsbl Augenheilkd 1994; 204: 465–467
- Weleber R G, Denman S T, Hanifin J M, Cunningham W J. Abnormal retinal function associated with isotretinoin therapy for acne. Arch Ophthalmol 1986; 104: 831–837
- Brown R D, Grattan C E. Visual toxicity of synthetic retinoids. Br J Ophthalmol 1989; 73: 286–288